, Guidelines: clinical management and treatment of HIV infected adults in Europe, Available, 2009.
, Rapid feasibility appraisal in Malawi for the introduction of revised WHO ART recommendations, Program and Abstracts of the 28th International AIDS Conference, 2009.
, Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival, The Journal of Infectious Diseases, vol.197, issue.9, pp.1324-1332, 2008.
DOI : 10.1086/587184
, When to Start Antiretroviral Therapy in Resource-Limited Settings, Annals of Internal Medicine, vol.151, issue.3, pp.157-166, 2009.
DOI : 10.7326/0003-4819-151-3-200908040-00138
, Cost-Effectiveness of HIV Treatment in Resource-Poor Settings ??? The Case of C??te d'Ivoire, New England Journal of Medicine, vol.355, issue.11, pp.1141-1153, 2006.
DOI : 10.1056/NEJMsa060247
, Cost-effectiveness in health and medicine, 1996.
, FXHistory: historical currency exchange rates Available: http://www.oanda.com/currency/average, 2009.
, Healthy life expectancy in 191 countries, 1999, The Lancet, vol.357, issue.9269, pp.1685-1691, 1999.
DOI : 10.1016/S0140-6736(00)04824-8
, Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients, AIDS, vol.22, issue.3, pp.385-393, 2008.
DOI : 10.1097/QAD.0b013e3282f3f16d
, The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire, Antivir Ther, vol.12, pp.543-551, 2007.
, Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural Models, American Journal of Epidemiology, vol.158, issue.7, pp.687-694, 2003.
DOI : 10.1093/aje/kwg206
, Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures - a meta-analysis, International Journal of STD & AIDS, vol.19, issue.5, 2008.
DOI : 10.1258/ijsa.2007.007248
, CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.4, pp.464-469, 2006.
DOI : 10.1097/01.qai.0000225729.79610.b7
, Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa, AIDS, vol.21, issue.3, pp.335-341, 2007.
DOI : 10.1097/QAD.0b013e328011efac
, Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C??te d'Ivoire: a randomised trial, The Lancet, vol.353, issue.9163, pp.1463-1468, 1999.
DOI : 10.1016/S0140-6736(98)07399-1
, Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in C??te d???Ivoire: a trial-based analysis, AIDS, vol.19, issue.12, pp.1299-1308, 2005.
DOI : 10.1097/01.aids.0000180101.80888.c6
, Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV, New England Journal of Medicine, vol.354, issue.3, pp.251-260, 2006.
DOI : 10.1056/NEJMoa051871
, Cost???Effectiveness of Tenofovir as First???Line Antiretroviral Therapy in India, Clinical Infectious Diseases, vol.50, issue.3, pp.416-425, 2008.
DOI : 10.1086/649884
, Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model, The Lancet, vol.371, issue.9622, pp.1443-1451, 2008.
DOI : 10.1016/S0140-6736(08)60624-8
, Cost-effectiveness of HIV Monitoring Strategies in Resource-Limited Settings, Archives of Internal Medicine, vol.168, issue.17, 1910.
DOI : 10.1001/archinternmed.2008.1
, WHO: Treat HIV patients sooner Available: http://www.statesman.com/life/health-medical/who-treat- hiv-patients-sooner-90329.html, 2009.
, Kenya: AIDS drug to be withdrawn Available: http://allafrica.com/stories, 2009.
, Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa, AIDS, vol.22, issue.15, pp.1897-1908, 2008.
DOI : 10.1097/QAD.0b013e32830007cd
URL : https://hal.archives-ouvertes.fr/inserm-00266588
, Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings, Current Opinion in HIV and AIDS, vol.5, issue.1, pp.18-26, 2010.
DOI : 10.1097/COH.0b013e328333850f
, Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-954, 1997.
DOI : 10.7326/0003-4819-126-12-199706150-00003
, Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort, Antivir Ther, vol.12, pp.753-760, 2007.
, Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV???Infected Adults in Africa Initiating Antiretroviral Therapy, Clinical Infectious Diseases, vol.46, issue.8, pp.1271-1281, 2008.
DOI : 10.1086/533468
, Changes in Renal Function Associated with Tenofovir Disoproxil Fumarate Treatment, Compared with Nucleoside Reverse???Transcriptase Inhibitor Treatment, Clinical Infectious Diseases, vol.40, issue.8, pp.1194-1198, 2005.
DOI : 10.1086/428840
, Cost-effectiveness of antiretroviral treatment for HIV-positive adults in a South African township. Médecins Sans Frontières and the Health Systems Trust, Available, 2004.
, When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African costeffectiveness study, Antivir Ther, vol.11, pp.63-72, 2006.